Fundraising Foxvial
3 known investors
Find your way into vial
Sign up to see every warm intro you have to vial
- Paths you didn't know you had: your email and LinkedIn already hold routes to the vial team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vial develops first- and best-in-class biologic therapeutics — including RNA, antibody, and small molecule programs — for immunology and inflammatory disorders, using AI-driven target discovery and molecule design. It evaluates its programs through an in-house clinical trial platform.
Founders & leadership
AB
Andrew BrackinFounder
SB
Simon BurnsFounder
Investors · 3
.png)
Frequently asked questions
- What does vial do?
- Vial develops first- and best-in-class biologic therapeutics — including RNA, antibody, and small molecule programs — for immunology and inflammatory disorders, using AI-driven target discovery and molecule design. It evaluates its programs through an in-house clinical trial platform.
- Who are vial's investors?
- vial's investors include BoxGroup, Byers Capital, General Catalyst.